|« Previous month||Next month »|
31-Oct-2013 - Lonza says its pharmaceutical business ‘performed as expected’ in the third quarter and that its restructuring efforts – which have seen it cut nearly 800 jobs– are on track to...
31-Oct-2013 - The acquisition of Bend Research by Capsugel may be “a marriage made in heaven” for customers, the firms say, as the first drug delivery tech is transferred.
30-Oct-2013 - Novasep has confirmed it will keep supplying Amarin with omega-3 API as the US FDA withdraws special status afforded to Vascepa trial.
30-Oct-2013 - API, drug intermediates and formulations firm Granules India ended the second quarter of fiscal 2013 with higher revenue and profit thanks to gains made by all three of its units.
30-Oct-2013 - Teva CEO Jeremy Levin has resigned just days after he denied rumours he would leave and called the speculation "an invention."
29-Oct-2013 - French CMO Novasep has received the thumbs up from US regulators at two of its European API manufacturing facilities.
29-Oct-2013 - Novo Nordisk has recalled 30 batches of a prefilled insulin product following a dosage error at a manufacturing facility in China.
29-Oct-2013 - GSK has teamed up with Brazilian researchers to develop ‘sustainable chemistry’ processes it will use to make drug manufacturing greener.
29-Oct-2013 - Welcome to in-Pharmatechnologist's People (not!) on the Move, with Teva's CEO denying he is contemplating resigning following reports he had fallen out with the Board over recent job cuts.
28-Oct-2013 - Dow says the acquisition of partner Bend Research is “good news” and will strengthen its developments in solving solubility and bioavailability issues in drug formulation.
28-Oct-2013 - Regulatory pressure for risk-based supply chain management is increasing excipient suppliers’ audit burden according to the team preparing to launch the 'excipact' certification scheme as an independent association.
28-Oct-2013 - Drug giant GlaxoSmithKline says operations have restarted at an OTC plant forced to close last week following a methane leak.
23-Oct-2013 - Catalent has announced two new softgel solutions as it adds greater versatility to its Advanced Technologies Business Unit.
23-Oct-2013 - Omega-3 supplier BASF will continue to produce the API for Amarin, as well as its competitor GlaxoSmithKline, despite an FDA panel saying that Amarin’s drug should not be approved for...
23-Oct-2013 - Indian manufacturing heavyweight Mylan Laboratories is looking to build off its major acquisition of Agila with a number of smaller acquisitions, while Natco is about to receive a cash infusion...
22-Oct-2013 - Linking peptide and small molecule drugs to albumin will improve pharmacokinetics, says Almac as it partners its manufacturing capabilities with Novozymes’ half-life extension platform.
22-Oct-2013 - Teva subsidiary Pliva has opened a new $100m (€73m) oral dosage manufacturing facility in Zagreb, Croatia to increase its export of tablets and capsules to the US and EU.
22-Oct-2013 - Azelis says its partnership with JH Nanhang (JHNH) will feed a large demand for polyvinylpyrolidones (PVP) excipients and bring the China-made ingredients to new markets.
21-Oct-2013 - Drugmakers, fine chemicals firms, delivery technology manufacturers and processing system developers from around the world meet in Frankfurt, Germany.
21-Oct-2013 - News from Mylan in Europe and Johnson & Johnson tops this week's in-Pharmatechnologist.com's People on the Move.
21-Oct-2013 - In calling an unregistered product ‘fake,’ the Ghanaian FDA has sparked a media war with industry, but are critics using this as an excuse to knock the regulators whilst importers...
21-Oct-2013 - Airport customs in Zurich, Switzerland announced Friday that they intercepted more than a million counterfeit drugs labelled as Pfizer’s Xanax.
17-Oct-2013 - The US Government Shutdown has delayed the regulatory review of a new egg-free influenza vaccine production process developed by Protein Sciences.
17-Oct-2013 - US and French regulators have given Oxford BioMedica the go ahead to restart studies of three eye drugs it is developing with Sanofi after an impurity found in trial materials...
17-Oct-2013 - Cirrus Pharmaceuticals has received a grant to investigate the effect of excipient concentration and API molecule size on metered dose inhaler (MDI) formulations.
|« Previous month||Next month »|